Ascendent Capital Partners

,
www.ascendentcp.com

Ascendent Capital Partners is a private equity firm focused on acquiring and investing in China-related companies. The Firm looks to leverage its network and experience when working with and helping companies grow. Ascendant Capital Partners has offices in Shanghai and Hong Kong.


M&A Summary

Buy vs Sell

Top M&A Advisors

Join Mergr to view the latest updates and news from Ascendent Capital Partners.

In the last 3 years, Ascendent Capital Partners has acquired 1 company.

Ascendent Capital Partners’ most common sector for investment is life science (100%). The Firm’s most common investment types include going private (100%). In total, Ascendent Capital Partners has invested in 1 US state. Its largest (disclosed) acquisition occurred in 2017 when it acquired SciClone Pharmaceuticals for $605M.

Join Mergr to view Ascendent Capital Partners’ full profile and discover more middle-market private equity firms just like it.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 113K M&A Transactions
  • 123K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 37K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.